My name is Benjamin Zohar, NCACIP. As an intervention specialist supporting families across New York City, Long Island, and the Hudson Valley, I’m increasingly being asked about the risks connected to kratom and its newer, more potent byproducts — especially 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MP).
I’m sharing this information because many New Yorkers are unaware that some kratom-related substances can behave like powerful synthetic opioids. Families often contact me after seeing unexpected withdrawal symptoms, respiratory depression, or signs of dependence in a loved...